Pseudomonas aeruginosa is a dominant pathogen in people with cystic fibrosis (CF)
contributing to morbidity and mortality. Its tremendous ability to adapt greatly facilitates its …

Multidrug-resistant Gram-negative bacterial infections are exponentially increasing, posing
one of the most urgent global healthcare and economic threats. Due to the lack of new …

The rise of multi-drug resistant (MDR) pathogens poses a significant challenge to the field of
infectious disease treatment. To overcome this problem, novel strategies are being explored …

Biofilm formation by Aeromonas hydrophila in the food industry poses significant challenges
to food safety and quality. Therefore, this comprehensive review aimed to provide insights …

Pseudomonas aeruginosa is an opportunistic pathogen responsible for acute hospital-
acquired infections. This review described various therapeutic approaches to treat infections …

Since the introduction of quinolone and fluoroquinolone antibiotics to treat bacterial
infections in the 1960s, there has been a pronounced increase in the number of bacterial …

Although the whole world is currently observing the global battle against COVID-19, it
should not be underestimated that in the next 30 years, approximately 10 million people per …

Auranofin (AF) is a gold-based compound with a well-known pharmacological and
toxicological profile, currently used in the treatment of some severe forms of rheumatoid …

Oxytetracycline (OTC) is a broad-spectrum antibiotic widely used in aquaculture, resulting in
contamination of aquatic environments. In a previous study, we observed significant effects …

Aminoacyl-tRNA synthetases (aaRSs) are promising drug targets due to their essential roles
in protein translation. Although current inhibitors primarily occupy one or two of the three …